Centene (NYSE:CNC) Issues FY 2025 Earnings Guidance

Centene (NYSE:CNC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.950. The company issued revenue guidance of -.

Centene Trading Up 2.8 %

Shares of CNC stock opened at $60.58 on Thursday. Centene has a twelve month low of $55.03 and a twelve month high of $80.59. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $60.04 and its two-hundred day moving average is $62.88. The company has a market capitalization of $30.05 billion, a P/E ratio of 9.71, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. The company had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same period last year, the firm earned $0.45 EPS. Equities analysts forecast that Centene will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CNC. Argus downgraded Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Wells Fargo & Company reduced their target price on Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research report on Friday, February 14th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and lifted their price target for the company from $79.00 to $80.00 in a report on Friday, December 13th. Cantor Fitzgerald reiterated an “overweight” rating and set a $90.00 price objective on shares of Centene in a report on Wednesday, December 11th. Finally, Barclays upped their price target on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, Centene has an average rating of “Moderate Buy” and a consensus target price of $79.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.